NCT06077877 2026-02-02A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid TumorsGlaxoSmithKlinePhase 1/2 Active not recruiting42 enrolled